Finally, gain-and-loss of function studies demonstrated its role in preventing invasive capabilities of HCC cells through mesenchymal epithelial transition factor (c-Met) indirect targeting and reported the oncogene c-Myc among miR-148a transcriptional inhibitors contributing to its downregulation during hepatocarcinogenesis [42]. The gene discussed is MYC; the disease is hepatocellular carcinoma.